is tirzepatide still in shortage news FDA confirms over, gives compounders a grace period Tirzepatide is NO longer – Mounjaro and Zepbound Are No – The Tirzepatide Shortage Is Over:

Underlying Health Conditions: Health conditions that contribute to weight gain, such as hormonal imbalances or other medical issues, can complicate weight maintenance

Currently, the medication is being tested in phase 3 trials, and FDA approval may come as early as 2027

In more severe or prolonged cases, subacute combined degeneration of the spinal cord can occur a serious neurological complication

Where Is Tirzepatide Used

For this reason, some healthcare providers use NAC alongside other medications to help treat some diseases and conditions related to oxidative stress and inflammation, including polycystic ovary syndrome (PCOS), ulcerative colitis, and neurodegenerative diseases like Alzheimers and Parkinsons

The evidence is weak